+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Medical Transdermal Patch Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283249
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical Transdermal Patches: Executive Overview

Medical transdermal patches deliver active ingredients through the skin and are used across pain management, hormone therapy, cardiovascular care, neurological treatment, and smoking cessation. Their value proposition centers on sustained delivery, reduced dosing frequency, and avoidance of gastrointestinal absorption. Adoption depends on clinical suitability, skin tolerability, adherence benefits, regulatory requirements, and reliable manufacturing quality.

How Delivery Needs Are Reshaping Transdermal Patch Use

The landscape is shifting toward patches that improve adherence, provide more consistent drug exposure, and support patient-centered treatment routines. Development priorities include better adhesion across daily activities, reduced irritation, precise dosing, improved usability for older adults, and compatibility with combination therapies. Regulatory scrutiny remains focused on bioequivalence, residual drug content, dose uniformity, stability, and safe disposal.

Artificial Intelligence Strengthens Design, Quality, and Patient Support

Artificial intelligence can contribute to transdermal patch development by analyzing formulation variables, skin-permeation data, adhesive performance, and manufacturing-process signals. In production, machine-learning tools may help identify anomalies earlier and support predictive maintenance or visual inspection. In clinical and commercial settings, analytics can help identify adherence risks and personalize reminders, but implementation requires validated datasets, explainable models, cybersecurity controls, and appropriate human oversight.

Regional Insights Across the Global Transdermal Landscape

North America emphasizes prescription access, clinical evidence, payer scrutiny, and advanced manufacturing controls. Europe combines harmonized regulatory expectations with strong attention to product quality, environmental handling, and patient safety. Asia-Pacific is shaped by expanding healthcare access, aging populations, domestic pharmaceutical capabilities, and varied regulatory pathways. Latin America presents opportunities linked to broader treatment access while requiring careful navigation of reimbursement and distribution differences. The Middle East is influenced by public-sector procurement, specialty-care development, and import requirements. Africa’s adoption depends on affordability, supply continuity, healthcare infrastructure, and training for appropriate use.

Group Insights: Trade, Regulation, and Health-System Priorities

ASEAN markets reflect diverse regulatory systems and healthcare-access conditions, making local registration and distribution capability important. BRICS members combine large patient populations with differing domestic-production policies, reimbursement structures, and regulatory maturity. The European Union benefits from coordinated regulatory frameworks while retaining country-level variation in procurement and care delivery. G7 markets generally place strong emphasis on evidence, quality systems, pharmacovigilance, and patient convenience. GCC countries are influenced by centralized procurement, imported medicines, and expanding specialty services. NATO members span varied healthcare models, but supply resilience, emergency preparedness, and dependable pharmaceutical logistics are shared priorities.

Country Insights: Differentiated Adoption Conditions

Australia emphasizes regulated prescription supply and geographically resilient distribution. Brazil and Mexico require attention to public and private reimbursement, local registration, and uneven access across regions. Canada and the United States prioritize evidence, payer value, adherence, and quality compliance. China and India combine substantial healthcare demand with evolving regulation and manufacturing capabilities. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom are shaped by aging populations, established health systems, and close assessment of clinical value, safety, and procurement efficiency. Russia’s environment is influenced by domestic supply priorities, regulatory conditions, and distribution reliability.

Strategic Priorities for Transdermal Patch Leaders

Leaders should prioritize indications where sustained delivery or adherence improvement is clinically meaningful, supported by comparative evidence and patient-use research. Product programs should address adhesion, skin tolerability, dose consistency, packaging, and disposal from the outset. Regional strategies should align regulatory dossiers, reimbursement evidence, local partnerships, and supply planning with each health system. Manufacturers should strengthen process validation, supplier qualification, serialization where required, pharmacovigilance, and continuity planning. Artificial intelligence should be deployed selectively in validated workflows, with governance covering data quality, model performance, privacy, and accountability.

Research Methodology for the Executive Summary

This summary uses a structured secondary-research framework focused on the medical transdermal patch category. The analysis organizes evidence by therapeutic use, delivery technology, regulatory considerations, patient needs, manufacturing requirements, healthcare-system conditions, and geography. Regional, group, and country comparisons are qualitative and reflect differences in access, regulation, demographics, procurement, infrastructure, and supply resilience. No market estimates, market shares, forecasts, or company-specific claims are included.

Conclusion: Competing Through Clinical Utility and Execution

Medical transdermal patches remain relevant where controlled delivery, convenience, and adherence can improve treatment experience or outcomes. Success depends less on the patch format alone than on evidence of clinical utility, dependable adhesion and tolerability, robust quality systems, and fit with local healthcare economics. Organizations that combine patient-centered design with disciplined regulatory, manufacturing, data, and supply-chain practices will be best positioned to develop durable value across diverse markets.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Transdermal Patch Market, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches
7.1. Introduction
7.2. Matrix Transdermal Patches
7.3. Reservoir Transdermal Patches
8. Medical Transdermal Patch Market, by Drug Category
8.1. Introduction
8.2. Pain Management Patches
8.3. Hormone Delivery Patches
8.4. Cardiovascular Drug Patches
9. Medical Transdermal Patch Market, by Release Mechanism
9.1. Introduction
9.2. Continuous
9.3. Controlled
10. Medical Transdermal Patch Market, by Adhesive Type
10.1. Introduction
10.2. Silicone
10.3. Acrylic
11. Medical Transdermal Patch Market, by Application
11.1. Introduction
11.2. Acute Therapy
11.3. Chronic Disease Management
12. Medical Transdermal Patch Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Medical Transdermal Patch Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Medical Transdermal Patch Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agile Therapeutics Inc.
16.2. Bayer AG
16.3. Dr. Reddy’s Laboratories Ltd.
16.4. Endo International plc
16.5. GlaxoSmithKline plc
16.6. Henan Lingrui Pharmaceutical Ltd.
16.7. Hisamitsu Pharmaceutical Co., Inc.
16.8. Johnson & Johnson Services, Inc.
16.9. Luye Pharma Group Ltd.
16.10. Medherant Ltd.
16.11. Mundipharma International Ltd.
16.12. Nitto Denko Corporation
16.13. Novartis AG
16.14. Purdue Pharma L.P.
16.15. Samyang Biopharmaceuticals Corp.
16.16. Sanofi SA
16.17. Teikoku Seiyaku Co., Ltd.
16.18. Teva Pharmaceutical Industries Ltd.
16.19. Viatris Inc.
16.20. Zydus Lifesciences Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medical Transdermal Patch Market, Years Considered for the Study
FIGURE 2. Global Medical Transdermal Patch Market, Research Design
FIGURE 3. Global Medical Transdermal Patch Market, Research Framework
FIGURE 4. Global Medical Transdermal Patch Market, Data Triangulation
FIGURE 5. Global Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2025 vs 2032 (%)
FIGURE 7. Global Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medical Transdermal Patch Market Size, by Drug Category, 2025 vs 2032 (%)
FIGURE 9. Global Medical Transdermal Patch Market Size, by Drug Category, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medical Transdermal Patch Market Size, by Release Mechanism, 2025 vs 2032 (%)
FIGURE 11. Global Medical Transdermal Patch Market Size, by Release Mechanism, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medical Transdermal Patch Market Size, by Adhesive Type, 2025 vs 2032 (%)
FIGURE 13. Global Medical Transdermal Patch Market Size, by Adhesive Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medical Transdermal Patch Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Medical Transdermal Patch Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medical Transdermal Patch Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Medical Transdermal Patch Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Medical Transdermal Patch Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medical Transdermal Patch Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Medical Transdermal Patch Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Medical Transdermal Patch Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medical Transdermal Patch Market Segmentation & Coverage
TABLE 2. Global Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 4. Global Matrix Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Matrix Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Matrix Transdermal Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Reservoir Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Reservoir Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Reservoir Transdermal Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 11. Global Pain Management Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Pain Management Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Pain Management Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Hormone Delivery Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Hormone Delivery Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Hormone Delivery Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Cardiovascular Drug Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Cardiovascular Drug Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Cardiovascular Drug Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 21. Global Continuous Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Continuous Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Continuous Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Controlled Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Controlled Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Controlled Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 28. Global Silicone Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Silicone Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Silicone Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Acrylic Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Acrylic Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Acrylic Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 35. Global Acute Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Acute Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Acute Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Chronic Disease Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Chronic Disease Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Chronic Disease Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Medical Transdermal Patch Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Asia-Pacific Medical Transdermal Patch Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Asia-Pacific Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 44. Asia-Pacific Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 45. Asia-Pacific Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 46. Asia-Pacific Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 48. North America Medical Transdermal Patch Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. North America Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 50. North America Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 51. North America Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 52. North America Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 53. North America Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 54. Latin America Medical Transdermal Patch Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Latin America Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 56. Latin America Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 57. Latin America Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 58. Latin America Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 59. Latin America Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 60. Europe Medical Transdermal Patch Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Europe Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 62. Europe Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 63. Europe Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 64. Europe Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 65. Europe Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 66. Middle East Medical Transdermal Patch Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Middle East Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 68. Middle East Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 69. Middle East Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 70. Middle East Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 71. Middle East Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 72. Africa Medical Transdermal Patch Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Africa Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 74. Africa Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 75. Africa Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 76. Africa Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 77. Africa Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 78. Global Medical Transdermal Patch Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. ASEAN Medical Transdermal Patch Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. ASEAN Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 81. ASEAN Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 82. ASEAN Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 83. ASEAN Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 84. ASEAN Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 85. GCC Medical Transdermal Patch Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. GCC Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 87. GCC Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 88. GCC Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 89. GCC Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 90. GCC Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. European Union Medical Transdermal Patch Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. European Union Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 93. European Union Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 94. European Union Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 95. European Union Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 96. European Union Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. BRICS Medical Transdermal Patch Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. BRICS Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 99. BRICS Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 100. BRICS Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 101. BRICS Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 102. BRICS Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. G7 Medical Transdermal Patch Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. G7 Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 105. G7 Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 106. G7 Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 107. G7 Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 108. G7 Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. NATO Medical Transdermal Patch Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. NATO Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 111. NATO Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 112. NATO Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 113. NATO Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 114. NATO Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. Global Medical Transdermal Patch Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. United States Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 117. United States Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 118. United States Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 119. United States Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 120. United States Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 121. United States Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Canada Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 123. Canada Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 124. Canada Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 125. Canada Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 126. Canada Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 127. Canada Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Mexico Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 129. Mexico Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 130. Mexico Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 131. Mexico Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 132. Mexico Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 133. Mexico Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Brazil Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 135. Brazil Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 136. Brazil Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 137. Brazil Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 138. Brazil Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 139. Brazil Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. United Kingdom Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 141. United Kingdom Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 142. United Kingdom Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 143. United Kingdom Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 144. United Kingdom Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 145. United Kingdom Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Germany Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 147. Germany Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 148. Germany Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 149. Germany Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 150. Germany Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 151. Germany Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. France Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 153. France Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 154. France Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 155. France Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 156. France Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 157. France Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. Russia Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 159. Russia Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 160. Russia Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 161. Russia Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 162. Russia Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 163. Russia Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. Italy Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 165. Italy Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 166. Italy Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 167. Italy Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 168. Italy Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 169. Italy Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Spain Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 171. Spain Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 172. Spain Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 173. Spain Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 174. Spain Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 175. Spain Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. China Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 177. China Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 178. China Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 179. China Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 180. China Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 181. China Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. India Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 183. India Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 184. India Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 185. India Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 186. India Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 187. India Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. Japan Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 189. Japan Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 190. Japan Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 191. Japan Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 192. Japan Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 193. Japan Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. Australia Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 195. Australia Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 196. Australia Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 197. Australia Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 198. Australia Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 199. Australia Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. South Korea Medical Transdermal Patch Market Size, 2017-2032 (USD Million)
TABLE 201. South Korea Medical Transdermal Patch Market Size, by Patch Type Matrix Transdermal Patches Reservoir Transdermal Patches, 2017-2032 (USD Million)
TABLE 202. South Korea Medical Transdermal Patch Market Size, by Drug Category, 2017-2032 (USD Million)
TABLE 203. South Korea Medical Transdermal Patch Market Size, by Release Mechanism, 2017-2032 (USD Million)
TABLE 204. South Korea Medical Transdermal Patch Market Size, by Adhesive Type, 2017-2032 (USD Million)
TABLE 205. South Korea Medical Transdermal Patch Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Global Medical Transdermal Patch Market Share, by Key Player, 2025
TABLE 207. Global Medical Transdermal Patch Market, Key Experts

Companies Mentioned

  • Agile Therapeutics Inc.
  • Bayer AG
  • Dr. Reddy’s Laboratories Ltd.
  • Endo International plc
  • GlaxoSmithKline plc
  • Henan Lingrui Pharmaceutical Ltd.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Luye Pharma Group Ltd.
  • Medherant Ltd.
  • Mundipharma International Ltd.
  • Nitto Denko Corporation
  • Novartis AG
  • Purdue Pharma L.P.
  • Samyang Biopharmaceuticals Corp.
  • Sanofi SA
  • Teikoku Seiyaku Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Limited